Literature DB >> 2493504

cDNA cloning and expression of human complement component C2.

T Horiuchi1, K J Macon, V J Kidd, J E Volanakis.   

Abstract

A full-length cDNA clone for C component C2 was isolated from a human liver cDNA library in lambda gt11 by initially screening with an affinity-purified rabbit anti-C2 antibody and then using the isolated partial C2 cDNA as a probe for re-screening the library. The cDNA insert of clone lambda C2HL5-3 was sequenced in its entirety. It consisted of 2961 nucleotides including a 5' untranslated region of 388 nucleotides, followed by a 60 nucleotide region coding for a putative signal peptide, a 2196 nucleotide region coding for the 732 amino acids of the mature C2 polypeptide, and a 317 nucleotide long 3' untranslated region. Comparison of the nucleotide sequence to the previously reported C2 cDNA sequence showed two major differences. First, the 5' untranslated region of C2HL5-3 was 352 nucleotides longer and included four ATG followed by in-frame termination codons. Second, nucleotide residue 1987 was a C instead of a G, resulting in a change of amino acid residue 513 from Leu to Phe and in the appearance of an EcoRI site. The full-length C2 cDNA was cloned into the expression vector p91023(B). Transfection of the recombinant plasmid in COS cells resulted in the secretion of a protein with antigenicity and hemolytic activity similar to those of native C2. Western blot analysis indicated that secreted rC2 had the same apparent m.w. as C2 in human serum. Northern blot analysis of total RNA isolated from transfected COS cells showed two bands of C2 mRNA, both of which were longer than human liver C2 mRNA and represent transcripts generated by the vector-C2 construct.

Entities:  

Mesh:

Substances:

Year:  1989        PMID: 2493504

Source DB:  PubMed          Journal:  J Immunol        ISSN: 0022-1767            Impact factor:   5.422


  11 in total

1.  The crystal structure of C2a, the catalytic fragment of classical pathway C3 and C5 convertase of human complement.

Authors:  Vengadesan Krishnan; Yuanyuan Xu; Kevin Macon; John E Volanakis; Sthanam V L Narayana
Journal:  J Mol Biol       Date:  2006-12-19       Impact factor: 5.469

2.  The structure of C2b, a fragment of complement component C2 produced during C3 convertase formation.

Authors:  Vengadesan Krishnan; Yuanyuan Xu; Kevin Macon; John E Volanakis; Sthanam V L Narayana
Journal:  Acta Crystallogr D Biol Crystallogr       Date:  2009-02-20

3.  Allelic associations of multiple RFLPs of the gene encoding complement protein C2.

Authors:  Z B Zhu; J E Volanakis
Journal:  Am J Hum Genet       Date:  1990-05       Impact factor: 11.025

4.  Individuals with IgA deficiency and common variable immunodeficiency share polymorphisms of major histocompatibility complex class III genes.

Authors:  F M Schaffer; J Palermos; Z B Zhu; B O Barger; M D Cooper; J E Volanakis
Journal:  Proc Natl Acad Sci U S A       Date:  1989-10       Impact factor: 11.205

5.  Major histocompatibility complex class III genes and susceptibility to immunoglobulin A deficiency and common variable immunodeficiency.

Authors:  J E Volanakis; Z B Zhu; F M Schaffer; K J Macon; J Palermos; B O Barger; R Go; R D Campbell; H W Schroeder; M D Cooper
Journal:  J Clin Invest       Date:  1992-06       Impact factor: 14.808

6.  Molecular heterogeneity in deficiency of complement protein C2 type I.

Authors:  X Wang; A Circolo; M L Lokki; P G Shackelford; R A Wetsel; H R Colten
Journal:  Immunology       Date:  1998-02       Impact factor: 7.397

7.  Shared HLA class II-associated genetic susceptibility and resistance, related to the HLA-DQB1 gene, in IgA deficiency and common variable immunodeficiency.

Authors:  O Olerup; C I Smith; J Björkander; L Hammarström
Journal:  Proc Natl Acad Sci U S A       Date:  1992-11-15       Impact factor: 11.205

8.  Role of protein kinase C activation in synthesis of complement components C2 and factor B in interferon-gamma-stimulated human fibroblasts, glioblastoma cell line A172 and monocytes.

Authors:  I Watanabe; T Horiuchi; S Fujita
Journal:  Biochem J       Date:  1995-01-15       Impact factor: 3.857

9.  Production and interferon-gamma-mediated regulation of complement component C2 and factors B and D by the astroglioma cell line U105-MG.

Authors:  S R Barnum; Y Ishii; A Agrawal; J E Volanakis
Journal:  Biochem J       Date:  1992-10-15       Impact factor: 3.857

10.  Nonsense mutations at Arg-1947 in two cases of familial neurofibromatosis type 1 in Japanese.

Authors:  T Horiuchi; N Hatta; M Matsumoto; H Ohtsuka; F S Collins; Y Kobayashi; S Fujita
Journal:  Hum Genet       Date:  1994-01       Impact factor: 4.132

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.